Z Squared Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Z Squared Inc.
- Former names
- Coeptis Therapeutics Holdings, Inc. Bull Horn Holdings Corp.
- Ownership
- Public
- Status
- Active
- SIC code
- 6199 — Finance Services
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Fort Lauderdale
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ZSQR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001759186
- EIN
- 98-1465952
Board of directors
-
Adam Craig Sohn · DirectorSince 2026
-
Bryan Eric Fuerst · DirectorSince 2026
-
Chris Calise · DirectorSince 2023
-
Christine Elise Sheehy · Director · CFO and SecretarySince 2023
-
Christopher P. Cochran · DirectorSince 2023
-
Daniel Alexander Yerace · Director · VP OperationsSince 2023
-
David Elias Halabu · Director · Co-Chief Executive OfficerSince 2026
-
David Mehalick · Director · CEO and PresidentSince 2023
-
Gene Salkind · DirectorSince 2023
-
Kenneth Lyle Cooper · DirectorSince 2026
-
Michelle Ellen Burke · Director · Co-Chief Executive OfficerSince 2026
-
Philippe Deschamps · DirectorSince 2023
-
Tara DeSilva · DirectorSince 2023
Chief executives
David Elias Halabu
· Co-Chief Executive Officer
Since April 2026
Michelle Ellen Burke
· Co-Chief Executive Officer
Since April 2026
David Mehalick
· CEO and President
Until April 2026
· Former
Director election results
Annual meeting of January 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.8%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
Board connections
1 of this board's directors also sit on 1 other board.
- via Gene Salkind
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $3,920
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Schadel Christopher Ryan Officer (Chief Marketing Officer) | Open-market purchase | +1,000 | $3.92 | $3,920 |
| Apr 30, 2026 | BSG Series CM, LLC 10% owner | Other | −41,521,276 | — | — |
| Apr 27, 2026 | Michelle Ellen Burke Director, Officer (Co-Chief Executive Officer) | Grant or award | +16,447 | — | — |
| Feb 11, 2026 | Philippe Deschamps Director | Option exercise | +5,700 | $10.56 | $60,192 |
| Feb 11, 2026 | Cogley Brian Officer (Chief Financial Officer) | Option exercise | +10,000 | $10.56 | $105,600 |
| Feb 11, 2026 | Chris Calise Director | Option exercise | +5,700 | $10.56 | $60,192 |
| Feb 11, 2026 | David Mehalick Director, Officer (CEO and President), 10% owner | Option exercise | +148,875 | $7.05 | $1,049,569 |
| Feb 11, 2026 | Christopher P. Cochran Director | Option exercise | +5,700 | $10.56 | $60,192 |
| Feb 11, 2026 | Christine Elise Sheehy Officer (VP Compliance and Secy) | Option exercise | +1,000 | $10.56 | $10,560 |
| Feb 11, 2026 | Gene Salkind Director | Option exercise | +5,700 | $10.56 | $60,192 |
| Feb 11, 2026 | Daniel Alexander Yerace Director, Officer (VP Operations) | Option exercise | +10,000 | $10.41 | $104,100 |
| Feb 11, 2026 | Tara DeSilva Director | Option exercise | +5,700 | $10.56 | $60,192 |
| Feb 11, 2026 | Philippe Deschamps Director | Grant or award | +3,250 | — | — |
| Feb 11, 2026 | Cogley Brian Officer (Chief Financial Officer) | Grant or award | +12,500 | — | — |
| Feb 11, 2026 | Chris Calise Director | Grant or award | +3,250 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.